Tweet Archive for hashtag “#ASCO16”
#ASCO16 news about #melanoma #skincancer
Online now: CheckMate064-nivolumab then ipilimumab more beneficial, more tox vs reverse order in #melanoma https://t.co/dpiSm9c5uq #ASCO16
— The Lancet Oncology (@TheLancetOncol) June 4, 2016
#ASCO16 news about #melanoma #skincancer
#keytruda shows some early benefit in some but not all sarcoma patients –Dr D'Angelo #asco16 pic.twitter.com/dtbGrmzhJj
— Eric D Whitman, MD (@Melanoma_doctor) June 5, 2016
#ASCO16 news about #melanoma #skincancer
#ASCO16 Join Arie Crown Th. 2.15PM Pr Robert @GustaveRoussy KEYNOTE-001 Results: 3-y overall survival for pts w/pembro in advanced #melanoma
— GustaveRoussy (@GustaveRoussy) June 6, 2016
#ASCO16 news about #melanoma #skincancer
Predictive biomarkers for #checkpoint inhibitors, #immunotherapy, in #melanoma and #crc. https://t.co/Ewhdr0cFvU #ASCO16 @VUMChealth
— AJMC-Oncology (@EBOncology) June 6, 2016
Precision medicine the theme at world’s biggest cancer conference #ASCO16 via @guardianscience theguardian.com/science/2016/j… #cancerawareness
RT @practiceupdate: .@ASCO : Pembrolizumab Improves Survival in #Melanoma ow.ly/qtXE300v2I0 #ASCO16 #skcsm
RT @MDAMelanomaOnc: Sat #ASCO16 poster 9548,M Rohlfs: BRAF +/ -MEK inhibition plus PD-1 checkpoint blockade for treatment of metastatic #me…
RT @MedscapeDerm: #ASCO16: findings from NEMO, other #Melanoma highlights. wb.md/1TYyVZH
#ASCO16 news about #melanoma #skincancer
In which patients with #melanoma should sentinel lymph node biopsy be pursued? https://t.co/WeFysq4uIg #ASCO16
— ASCO (@ASCO) June 4, 2016
#ASCO16 news about metastatic #melanoma #skincancer
The Evolving Treatment Landscape of Metastatic #Melanoma: From Ipilimumab to New Checkpoint Inhibitors https://t.co/yypM2sZmUP #ASCO16
— ASCO (@ASCO) June 4, 2016